Axillary intra-aortic balloon pump, biventricular assist device implantation and subsequent orthotopic heart transplantation in a patient with sickle cell trait.
Marcus TaylorZakariya MouyerPaul CallanSteve ShawRajamiyer VenkateswaranNnamdi NwaejikePublished in: Journal of surgical case reports (2022)
A 38-year-old male with sickle cell trait and acute refractory heart failure received an axillary intra-aortic balloon pump and short-term biventricular assist device. He underwent orthotopic heart transplantation 45 days later, which was complicated by major bleeding necessitating significant intra-operative transfusion. Support with veno-arterial extracorporeal membrane oxygenation was provided and successfully weaned five days later. He made a full recovery and remains alive and well 34 months after discharge. We hypothesize that the protective peri-operative measures undertaken, including normothermia during surgery and post-operative haemodynamic stability due to the use of mechanical circulatory support, conveyed a degree of protection against complications associated with sickle cell dysfunction and contributed to the successful outcome.
Keyphrases
- extracorporeal membrane oxygenation
- respiratory failure
- acute respiratory distress syndrome
- heart failure
- lymph node
- aortic dissection
- left ventricular
- cardiac resynchronization therapy
- aortic valve
- sentinel lymph node
- neoadjuvant chemotherapy
- genome wide
- minimally invasive
- pulmonary artery
- ultrasound guided
- liver failure
- cardiac surgery
- coronary artery bypass
- atrial fibrillation
- case report
- oxidative stress
- acute coronary syndrome
- risk factors
- gene expression
- dna methylation
- early stage
- radiation therapy
- coronary artery disease
- acute heart failure